Millie
your market intelligence analyst
Search Results
540 results
Your search is now limited to «Drugs» expert search.
DoctorsLounge 09/18/2019 13:00
To combat the increase in infective endocarditis, teams are needed that include cardiologists, infectious disease specialists, cardiac surgeons, nurses, addiction specialists, case managers and social workers, he said.
More from DoctorsLounge:
News-Medical.net 09/18/2019 12:08
This new trend predominantly affects young, white, poor men who also have higher rates of HIV, hepatitis C and alcohol abuse, according to new research published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
More from News-Medical.net:
PR Newswire 09/18/2019 08:40
Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system of the heart and its damaged or blocked valves and vessels.
More from PR Newswire:
ClinicalTrials.gov 09/18/2019 07:52
The diagnosis of hypertension is made in accordance with the 2017 guidelines of the American College of Cardiology / American Heart Association ACC / AHA.
More from ClinicalTrials.gov:
AstraZeneca’s Farxiga (dapagliflozin) has been granted fast track designation from the US Food and Drug Administration (FDA) for its use in reducing the risk of heart failure.
More from Pharmaceutical Business Review:
Patients with these high numbers and a history of cardiovascular disease have nearly six times the risk of suffering a heart attack, stroke or another cardiovascular event than those with cholesterol numbers in a healthier range.
More from United Press International - UPI (United States):
In Reply Dr Lucijanic and colleagues express concern about the proportion of patients randomized to the drug group of the trial who crossed over to receive an ablation, and the biases those crossovers may have introduced in the analysis. As noted in the publication, there were also crossovers among patients randomized to the ablation group, namely patients who did not undergo the ablation after being randomized. This could also have introduced bias. Our concern about crossovers in either direction and biases introduced by the crossovers was precisely why prespecified sensitivity analyses (as-treated and per-protocol analyses) were performed and reported and discussed in the online Supplement 3. The crossover of patients in the drug group to.
More from Journal of the American Medical Association - (JAMA):
ENDPOINTS 09/16/2019 11:11
A couple weeks after announcing that their diabetes drug cut the risk of CV death or worsening of heart failure by 26% in a landmark study, AstraZeneca announced that the FDA has granted fast track designation for Farxiga.
More from ENDPOINTS:
Healio News 09/16/2019 11:01
The FDA has granted fast track designation to the SGLT2 inhibitor dapagliflozin for reducing the risk for cardiovascular death or worsening heart failure among adults with heart failure with reduced or preserved ejection fraction, according to a press release from AstraZeneca.
More from Healio News:
FiercePharmaManufacturing 09/16/2019 09:10
When SGLT2 med Farxiga scored a major cardiovascular outcomes win last month, AstraZeneca touted the drug’s trial results as a game changer for the market.
More from FiercePharmaManufacturing:
Business Wire 09/16/2019 07:30
Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, said: “Heart failure affects approximately 64 million people worldwide, and about half will die within five years of diagnosis.
More from Business Wire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications